NCT04291599View on ClinicalTrials.gov

Initial Pain Management in Pediatric Pancreatitis: Opioid vs. Non-Opioid

PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Acute Pancreatitis
Interventions
DRUG

Ketorolac

Subjects will be randomized to either receive opioid (standard of care) or opioid-sparing analgesia.

DRUG

Opioid

Subjects will be randomized to either receive opioid (standard of care) or opioid-sparing analgesia

Trial Locations (1)

02115

RECRUITING

Boston Children's Hospital, Boston

All Listed Sponsors
collaborator

The National Pancreas Foundation

OTHER

lead

Boston Children's Hospital

OTHER